Skip to main content
News University of Excellence 07.2019
University of Excellence - Rector Prof. Dr. Dr. h.c. Michael Hoch celebrates the excellence decision
© Barbara Frommann/Uni Bonn

Honors & Funding

“We are a University of Excellence”

The University of Bonn is one of only eleven Universities of Excellence in Germany appointed today and one of two in North Rhine-Westphalia. With the six Clusters of Excellence acquired last September, the University of Bonn is the most successful university in the Germany-wide Excellence competition. We are happy and proud to be part of that excellent University.

We look forward to continue our excellent research in this great scientific environment.

Related news

News Marvin Supercomputer

Honors & Funding

Two years of the Marvin Supercomputer: Researchers in Bonn present their projects

—Two years after it went into operation, the University of Bonn celebrated the Marvin Supercomputer with a community event at the Research and Technology Center for Detector Physics (FTD). Researchers from various disciplines presented projects that had been carried out using high-performance computing and used the event as an opportunity for interdisciplinary exchange. A team lead by ImmunoSensation³ members Prof. Dr. Michael Hölzel (Institute of Experimental Oncology) and PD Dr. Gregor Hagelueken (Institute of Structural Biology) use Marvin to design new proteins.
View entry
Award Ceremony, SxDiagnostics

Honors & Funding

start2grow start-up competition awards “SxDiagnostics”

—The “SxDiagnostics” project from the University of Bonn and the University Hospital Bonn (UKB) prevailed against over 100 competing teams in the start2grow competition and placed in the (shared) 4th to 10th spots. Start2grow is organized nationwide by the Dortmund Economic Development Agency and celebrated its 25th anniversary this year.
View entry
Gut

Honors & Funding

Millions in funding for the new MikrobiomProCheck research project

—The human gut microbiome is as unique as a fingerprint. It plays a central role in chronic inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis. Yet its potential for diagnostics and personalized therapy for patients remains untapped. The MikrobiomProCheck research project aims to change this. To this end, the Leibniz Institute for Analytical Sciences (ISAS), the Universities of Bonn, Bielefeld, and Duisburg-Essen, Biofidus AG, and Lead Discovery Center GmbH are receiving approximately 3.4 million euros from the state government of NRW and the European Union.
View entry

Back to the news overview